Bafilomycin A1 inhibits SARS-CoV-2 infection in a human lung xenograft mouse model

Overview of attention for article published in Virology Journal, January 2023

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (82nd percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

So far, Altmetric has seen 13 X posts from 13 X users, with an upper bound of 47,598 followers.

RT @fdzaraf: - (エンドソーム酸性化阻害剤である)バフィロマイシンA1は,SARS-CoV-2の治療薬の候補となる可能性がある。(本研究では,レムデシビルと同等以上の作用が示されています) Epub 2023/1/31 バフィロマイシンA1はヒト肺を異種移植した…

バフィロマイシンA1 レムデシビルと同等

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 9 additional X posts.